Teva Pharmaceutical Industries Limited (TEVA) Earnings
|
Expand Research on TEVA
| Next EPS Date | 5/8/24 | EPS Growth Rate | +30.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +2.1% | Revenue Growth Rate | +0.8% |
| Average % Move 1-Wk after EPS | +2.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/26/22  |
 |
Q222 | $0.68 | $0.56 | +$0.12 | $3.8B | $3.78B |  |
 | | Details |
| 11/1/18 | |
Q318 | $0.65 | $0.54 | +$0.11 | $4.5B | $4.53B |  |
| | Details |
| 7/28/21 | |
Q221 | $0.59 | $0.59 | $0.00 | $3.9B | $4.04B | = | | | Details |
| 8/2/23 | Q223 | $0.56 | $0.53 | +$0.03 | $3.9B | $3.72B | = | | | Details | |
| 2/9/22 | |
Q421 | $0.77 | $0.73 | +$0.04 | $4.1B | $4.29B | |
| | Details |
| 5/7/20 | |
Q120 | $0.76 | $0.59 | +$0.17 | $4.4B | $4.15B | = | | | Details |
| 2/12/20 | |
Q419 | $0.62 | $0.61 | +$0.01 | $4.5B | $4.35B | = | | | Details |
| 2/13/17 | |
Q416 | $1.38 | $1.36 | +$0.02 | $6.25B | $6.26B | = | | | Details |
